MARC details
000 -LEADER |
fixed length control field |
03378cam a2200469 a 4500 |
001 - CONTROL NUMBER |
control field |
31377426 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20201215154246.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
940929s1994 enk 000 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0853692904 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780853692904: |
Terms of availability |
No price |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
NLM |
Transcribing agency |
NLM |
Modifying agency |
TMV |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
GBC |
Source |
thema |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MKG |
Source |
thema |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
TDCW |
Source |
thema |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1142 |
245 04 - TITLE STATEMENT |
Title |
The pharmaceutical codex : |
Remainder of title |
principles and practice of pharmaceutics. |
250 ## - EDITION STATEMENT |
Edition statement |
12th ed. / |
Remainder of edition statement |
editor, Walter Lund. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
London : |
Name of publisher, distributor, etc. |
Pharmaceutical Press, |
Date of publication, distribution, etc. |
1994. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xix, 1117 : |
Other physical details |
ill. |
500 ## - GENERAL NOTE |
General note |
CW108 |
500 ## - GENERAL NOTE |
General note |
CW118 |
500 ## - GENERAL NOTE |
General note |
CW116 |
500 ## - GENERAL NOTE |
General note |
"Published by direction of the Council of the Royal Pharmaceutical Society of Great Britain and prepared in the Pharmaceutical Division of the Society's Department of Pharmaceutical Sciences." |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Preparation and presentation of drugs as medicines -- Dosage forms -- Oral solids -- Oral liquids -- Solution properties -- Suspensions -- Emulsions -- Parenterals -- Aerosols -- Inhalation products -- Topical semi-solids -- Topical liquids and powders -- Ophthalmic products -- Rectal and vaginal products -- Product design, development and presentation -- Preformulation -- Formulation -- Modified-release drug delivery systems -- Biopharmaceutics and pharmacokinetic principles -- Rheology -- Stability of medicinal products -- Incompatibility. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Pharmaceutical packaging -- Storage -- Pharmaceutical aspects of clinical trials -- Statistics -- Preparation and supply of medicines -- Good manufacturing practice -- Licensing -- Design criteria for production facilities -- Process development -- Validation -- Dispensing procedures and practice-related guidelines -- Weighing, measuring and counting -- Infusion fluids: admixtures and administration -- Paediatric preparations -- Radiopharmaceuticals -- Cytotoxic drugs: handling precautions -- Medical gases -- Immunological products. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Pharmaceutical microbiology, sterile processing and contamination control -- Pharmaceutical microbiology -- Control of microbial contamination and the preservation of medicines -- Pyrogens -- Particulate contamination -- Sterilisation -- Aseptic processing -- Cleanrooms for pharmaceutical production -- Disinfectants and antiseptics -- Electrolyte replacement, nutrient fluids and dialysis solutions -- Electrolyte powders and oral rehydration fluids -- Parenteral and enteral nutrition fluids -- Peritoneal dialysis and haemodialysis preparations. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Nomenclature and miscellaneous data -- Nomenclature of organic compounds -- Miscellaneous data -- Monographs on drug substances. |
590 ## - LOCAL NOTE (RLIN) |
a |
154.98 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacopoeias |
Geographic subdivision |
Great Britain |
9 (RLIN) |
38150 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Health and Wellbeing. |
Source of heading or term |
ukslc |
9 (RLIN) |
32133 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Reference works |
Source of heading or term |
thema |
9 (RLIN) |
83324 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacology |
Source of heading or term |
thema |
9 (RLIN) |
83325 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical chemistry & technology |
Source of heading or term |
thema |
9 (RLIN) |
45034 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Lund, Walter. |
9 (RLIN) |
83326 |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Royal Pharmaceutical Society of Great Britain. |
Subordinate unit |
Council. |
9 (RLIN) |
83327 |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Royal Pharmaceutical Society of Great Britain. |
Subordinate unit |
Dept. of Pharmaceutical Sciences. |
9 (RLIN) |
83328 |
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
a |
170424 |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
a |
.b10266860 |
b |
multi |
c |
- |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
0 |
998 ## - LOCAL CONTROL INFORMATION (RLIN) |
Operator's initials, OID (RLIN) |
2 |
Cataloger's initials, CIN (RLIN) |
051215 |
First Date, FD (RLIN) |
m |
Local |
a |
-- |
- |
-- |
4 |